# Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly

> **NCT02342496** · NA · COMPLETED · sponsor: **Probi AB** · enrollment: 66 (actual)

## Conditions studied

- Low-grade Inflammation
- Increased Intestinal Permeability

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Active, only probiotics
- **DIETARY_SUPPLEMENT:** Active, blend of berries and probiotics

## Key facts

- **NCT ID:** NCT02342496
- **Lead sponsor:** Probi AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12-04
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2018-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02342496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02342496, "Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT02342496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
